[ET Net News Agency, 20 September 2016] Jacobson Pharma (02633) said its retail
offering was over-subscribed by about 5.11 times and the international offering was
moderately over-subscribed.
The offer price has been determined at HK$1.5 per share, with estimated net proceeds of
about HK$601.2 million.
Dealings in shares of Jacobson Pharma are expected to commence tomorrow morning, with a
board lot size of 2,000 shares each.
Jacobson Pharma is a Hong Kong-based company engaged in the development, production,
marketing and sale of generic drugs and proprietary Chinese medicines. (HL)